Mark your calendar for September 8th at 15:10 PM CEST during the EFMC Medicinal Chemistry 2026. Our Associate BD Director, Dr. Jackson (Cong) Huang will take the stage in Room Shanghai for Session 13—Antibody-Drug Conjugates: Advances in Targeted Therapies to share insights.
In this presentation, Dr. Huang will introduce a drug-resistant cell and cancer cell panel framework designed to support the systematic evaluation of synergistic dual-payload combinations, with the goal of identifying new strategies to overcome ADC resistance and expand therapeutic potential.
Want a copy of the presentation deck? DM us your email address, and we'll send it over after the event.
Visit us at Booth #33 during the event to learn more about our latest innovations in ADC resistance solutions and beyond!
Location: Basel, Switzerland
Date: September 6-10, 2026
Booth: #33
PREV：ICE Bioscience to Attend the EFMC Medici...
NEXT：There's no more
2026-08-13
2026-07-10
2026-06-15
2026-05-29
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
Get a quote
Go top
